Kristy M. Borawski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kristy M. Borawski has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Cindy L. Amundsen
Division of Urogynecology, Duke University Medical Center, Durham, North Carolina
1 shared publicationDaniel Rapoport
1 shared publicationGeorge D Webster
1 shared publicationGeorge D. Webster
Division of Urology, Duke University Medical Center, Durham, North Carolina
1 shared publicationJack R Walter
1 shared publication- Raymond T. Foster
Missouri Center for Female Continence and Advanced Pelvic Surgery, Department of Obstetrics, Gynecology, and Women's Health, University of Missouri School of Medicine, Columbia, MO 65212, USA
1 shared publication
Latest Publications
- 30 April 2009
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 181 (4) , 619
THE ADVANCE MALE SLING: PREDICTORS OF SUCCESS
- 30 April 2009
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 181 (4) , 619
THE ADVANCE MALE SLING: PREDICTORS OF SUCCESS
- 22 November 2006
- Published by Wiley in Neurourology and Urodynamics
- Vol. 26 (1) , 14-18
Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women
Aims: The purpose of this study was to determine whether a percutaneous needle electrode (PNE) technique or a surgical first stage lead placement (FSLP) better predicted whether a patient would progress to implantation of a pulse generator (IPG) in older urge incontinent women.Methods: Thirty subjects ≥55 years with refractory urge incontinence who had been selected to undergo a test stimulation procedure were randomized to either PNE or FSLP. Thirteen underwent PNE placement and seventeen underwent FSLP placement. If during the test stimulation period subjects had greater than 50% improvement in their incontinence parameters they qualified for permanent lead and/or IPG implantation of the Interstim® device.Results: Twenty‐one subjects (70%) responded to the test stimulation and underwent implantation, 15/17 (88%) in the FSLP group and 6/13 (46%) in the PNE group. Subjects who were randomized to the FSLP group were significantly more likely to proceed to implantation of the IPG (P = 0.02) than those in the PNE group. There was no significant difference in demographics, pre‐test stimulation incontinence parameters or post‐stimulation visual analog pain scores between the randomized groups or between test stimulation responders and non‐responders. When comparing FSLP and PNE responders, there was no significant difference in the percent improvement in 24‐hr pad weight, daily pad usage, or daily incontinence.Conclusion: FSLP better predicted progression to implantation of the IPG than a test stimulation with a PNE in an older urge incontinent cohort. Neurourol. Urodynam.
- 22 November 2006
- Published by Wiley in Neurourology and Urodynamics
- Vol. 26 (1) , 14-18
Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women
Aims: The purpose of this study was to determine whether a percutaneous needle electrode (PNE) technique or a surgical first stage lead placement (FSLP) better predicted whether a patient would progress to implantation of a pulse generator (IPG) in older urge incontinent women.Methods: Thirty subjects ≥55 years with refractory urge incontinence who had been selected to undergo a test stimulation procedure were randomized to either PNE or FSLP. Thirteen underwent PNE placement and seventeen underwent FSLP placement. If during the test stimulation period subjects had greater than 50% improvement in their incontinence parameters they qualified for permanent lead and/or IPG implantation of the Interstim® device.Results: Twenty‐one subjects (70%) responded to the test stimulation and underwent implantation, 15/17 (88%) in the FSLP group and 6/13 (46%) in the PNE group. Subjects who were randomized to the FSLP group were significantly more likely to proceed to implantation of the IPG (P = 0.02) than those in the PNE group. There was no significant difference in demographics, pre‐test stimulation incontinence parameters or post‐stimulation visual analog pain scores between the randomized groups or between test stimulation responders and non‐responders. When comparing FSLP and PNE responders, there was no significant difference in the percent improvement in 24‐hr pad weight, daily pad usage, or daily incontinence.Conclusion: FSLP better predicted progression to implantation of the IPG than a test stimulation with a PNE in an older urge incontinent cohort. Neurourol. Urodynam.